Change in nail colour to muscle pain: Be cautious of these Omicron symptoms

• Image Credit: Internet

• Jan 5, 2022 | moderator

Digital Desk : With the spread of the new Omicron variant already adding to the total Covid caseload in many countries, new symptoms of the new variant is putting experts and researchers on their toes while genome sequencing.

Omicron variant of coronavirus has rapidly spread its branch as researchers claim it to be more infectious than the Delta variant, but milder than its predecessor. Yet, a lot needs to be known as this is highly transmissible viral strain.

Although sore throat, common cold, loss of smell-taste continue to remain as the common symptoms of the infection, change in colour in skin, lips and nails have added to the new sightings of Omicron symptoms.

Also read : Is this Aryan Khan urinating in public? Check video to know the entire truth

The American Centre for Disease Control and Prevention (CDC) has reported people with Omicron coming with various other symptoms less visible in Covid variant. The Omicron symptoms recently found includes a wide range apart from high temperature, new or persistent cough.

The CDC while studying patients with Omicron symptoms have warned of nail beds changing colour to blur or grey, which immediately requires medical attention if sighted. CDC also warned people to watch out for pale, grey or blue coloured skin, lips as well, depending on our skin tone.

As per medical body, change in colour of skin, lips or nails might also indicate low levels of oxygen in the blood.

Scratchy throat, sneezing or running nose with mild muscle aches and fatigue have been concluded as general Omicron symptoms, according to a study from the ZOE symptom tracker app.

Also read : African swine flu panic in Majuli

The Omicron variant was first discovered in South Africa just over a month ago, but has then rapidly spread across the globe, with experts cautioning to strictly adhere to Covid appropriate behaviour.

Studies have shown Omicron to be good at evading the attacks of antibodies, but are far less successful in avoiding the second-line defenses of vaccines and prior infections: T-cells and B-cells.